Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06028932
Title A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Alessandro Santin
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.